Security key
88322Q108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 106,408,531
- Total 13F value
- $452,245,708
- Share change
- +5,633,218
- Put/Call ratio
- 35%
- SEC-reported price per share
- $4.25
- Number of holders
- 161
- Value change
- -$5,017,128
- Number of buys
- 92
- Number of sells
- 76
- Shares outstanding
- 159,699,810
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
161
Top holders
10
TGTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
TG THERAPEUTICS, INC. SEC filings
TG THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88322Q108
Recent filing periods:
Ownership snapshot
Top reported holders of TGTX - TG THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F
Highest disclosed value: $193,328,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $193.33M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$193.33M
VANGUARD GROUP INC
$115.37M
STATE STREET CORP
$91.57M
BlackRock Finance, Inc.
$84.98M
MAVERICK CAPITAL LTD
$63.5M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$193,328,000
20,328,841 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$115,366,000
12,130,963 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$91,568,000
9,628,584 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$84,978,000
8,935,578 shares
|
— | 31 Mar 2022 |
| MAVERICK CAPITAL LTD |
13F
Company
|
—
denominator unverified
|
$63,505,000
6,677,726 shares
|
— | 31 Mar 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
—
denominator unverified
|
$38,235,000
4,020,476 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
161
Shares
106,408,531
Rows available
161
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
169
Q2 2022 holders
161
Holder diff
-8
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend